ExxonMobil vs AbbVie

Side-by-side comparison of AI visibility scores, market position, and capabilities

AbbVie leads in AI visibility (90 vs 75)

ExxonMobil

LeaderEnergy & Utilities

Enterprise

Spring TX integrated oil and gas (NYSE: XOM) at $33.7B 2024 earnings, $339B revenue; Pioneer $60B acquisition doubles Permian to 1.3M BOE/day, $36B shareholder return, competing with Chevron and Shell.

AI VisibilityBeta
Overall Score
B75
Category Rank
#192 of 290
AI Consensus
54%
Trend
down
Per Platform
ChatGPT
66
Perplexity
78
Gemini
86

About

ExxonMobil Corporation is a Spring, Texas-based integrated oil, gas, and energy company — publicly traded on the New York Stock Exchange (NYSE: XOM) as an S&P 500 Energy component and one of the world's largest publicly traded companies by market capitalization — exploring, producing, refining, and marketing oil, natural gas, and petroleum products while advancing low-carbon technologies through approximately 62,000 employees worldwide. In fiscal year 2024, ExxonMobil reported earnings of $33.7 billion ($7.84 per diluted share), revenue of $339.24 billion, operating cash flow of $55.0 billion, free cash flow of $34.4 billion, and returned $36.0 billion to shareholders through dividends and share repurchases. ExxonMobil completed the landmark acquisition of Pioneer Natural Resources in May 2024 for approximately $60 billion — the largest acquisition in the company's history since the 1998 Exxon-Mobil merger — making ExxonMobil the dominant operator in the Permian Basin (West Texas/New Mexico), the most productive oil basin in the US with the lowest breakeven production costs globally. The Pioneer acquisition added 1.3 million acres in the Midland Basin, doubling ExxonMobil's Permian production capacity to 1.3 million barrels of oil equivalent per day by 2027. CEO Darren Woods has led ExxonMobil since 2017 through the COVID oil price collapse, the industry recovery, and the Pioneer acquisition that repositioned ExxonMobil as the premier Permian Basin operator.

Full profile

AbbVie

LeaderHealthcare

General

Global pharma company with $55B 2024 revenue; successfully diversifying beyond Humira with Skyrizi, Rinvoq, and $8.7B Cerevel neuroscience acquisition.

AI VisibilityBeta
Overall Score
A90
Category Rank
#9 of 1167
AI Consensus
60%
Trend
stable
Per Platform
ChatGPT
99
Perplexity
99
Gemini
83

About

AbbVie is a global research-based biopharmaceutical company focused on developing treatments for complex and serious diseases including immunology, oncology, neuroscience, aesthetics, and eye care. Spun off from Abbott Laboratories in 2013 and headquartered in North Chicago, Illinois, AbbVie rapidly became one of the world's top pharmaceutical companies on the strength of Humira — the world's best-selling drug for over a decade with peak annual sales exceeding $20 billion. AbbVie is listed on the NYSE and is a component of the S&P 500 and Dow Jones Industrial Average.

Full profile

AI Visibility Head-to-Head

75
Overall Score
90
#192
Category Rank
#9
54
AI Consensus
60
down
Trend
stable
66
ChatGPT
99
78
Perplexity
99
86
Gemini
83
71
Claude
96
78
Grok
95

Track AI Visibility in Real Time

Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.